Dror Bashan
Förmögenhet: 5 M $ per 2026-05-31
Förmögenhet: 5 M $ per 2026-05-31
Dror Bashan is currently President, Chief Executive Officer & Director at Protalix Biotherapeutics, Inc. since 2019.
Formerly, Mr. Bashan was Senior VP-Global Business Development at Teva Pharmaceutical Industries Ltd. Education includes undergraduate and MBA degrees from Tel-Aviv University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-30 | 2 532 934 ( 3,14 % ) | 5 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| PROTALIX BIOTHERAPEUTICS, INC. | Verkställande Direktör | 2019-06-30 |
| Företag | Position | Slut |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protalix Biotherapeutics, Inc.
Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån